Mid-Year Report

FORSCEY, PLLC for BARR LABORATORIES

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR.1432 - Preserve Access to Affordable Generics Act S. 1082 - Prescription Drug User Fee Amendments of 2007, Generic Biologics S.1145 - Patent Reform Act of 2007 HR.1908 - Patent Reform Act of 2007 Amendment SA 1025 (S. 1082) - To express the sense of the Senate with respect to follow-on biologics

LobbyistCovered position, as disclosed
MICHAEL A FORSCEY MANAGING PARTNER
JOHN STINSON PARTNER

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1082 (110th), H.R. 1908 (110th), H.R. 1432 (110th), S. 1145 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.